Savitha M. Rao

Array ( [id] => 8278514 [patent_doc_number] => 20120172388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-05 [patent_title] => 'Enhancement of Impaired Motor and Mental Functions, Using Dextromethorphan and Oxidase Enzyme Inhibitor' [patent_app_type] => utility [patent_app_number] => 13/415990 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10828 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745462 [patent_doc_number] => 20130085179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS' [patent_app_type] => utility [patent_app_number] => 13/417137 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12890 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8484214 [patent_doc_number] => 20120283620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'TREATMENT UTILIZING HYDROPHOBIC WEAK BASES CHEMOTHERAPEUTIC AGENTS AND ILLUMINATION' [patent_app_type] => utility [patent_app_number] => 13/414879 [patent_app_country] => US [patent_app_date] => 2012-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 22548 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13414879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264651 [patent_doc_number] => 20120164078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/410388 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15659 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13410388 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509204 [patent_doc_number] => 20120308612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR PREPARATION OF POORLY WATER SOLUBLE DRUGS WITH INCREASED STABILITY' [patent_app_type] => utility [patent_app_number] => 13/408994 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26994 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13408994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662354 [patent_doc_number] => 08809327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Sulfonamides as TRPM8 modulators' [patent_app_type] => utility [patent_app_number] => 13/407251 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 188898 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13407251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245390 [patent_doc_number] => 08609671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 13/407616 [patent_app_country] => US [patent_app_date] => 2012-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21967 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13407616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496573 [patent_doc_number] => 20120295982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'TREATING HUMAN MALE COPD PATIENTS WITH ORAL BEDORADRINE' [patent_app_type] => utility [patent_app_number] => 13/401622 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10121 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13401622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227180 [patent_doc_number] => 20120141388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'ANTIBACTERIAL DENTIFRICE EXHIBITING ENHANCED ANTIPLAQUE AND BREATH FRESHENING PROPERTIES' [patent_app_type] => utility [patent_app_number] => 13/372871 [patent_app_country] => US [patent_app_date] => 2012-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4471 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8221861 [patent_doc_number] => 20120136068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'AMELIORANT FOR RENAL INSUFFICIENCY' [patent_app_type] => utility [patent_app_number] => 13/367713 [patent_app_country] => US [patent_app_date] => 2012-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2206 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8577328 [patent_doc_number] => 08343537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-01 [patent_title] => 'Clay-based hemostatic agents and devices for the delivery thereof' [patent_app_type] => utility [patent_app_number] => 13/363270 [patent_app_country] => US [patent_app_date] => 2012-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 7312 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13363270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701576 [patent_doc_number] => 08394798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Compositions and methods for inducing neuronal differentiation' [patent_app_type] => utility [patent_app_number] => 13/356079 [patent_app_country] => US [patent_app_date] => 2012-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12231 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13356079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122144 [patent_doc_number] => 20130289066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'ANTI-ANGIOGENIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/979447 [patent_app_country] => US [patent_app_date] => 2012-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 7805 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648230 [patent_doc_number] => 08802240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells' [patent_app_type] => utility [patent_app_number] => 13/345194 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 99 [patent_no_of_words] => 70103 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8737829 [patent_doc_number] => 08409596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-02 [patent_title] => 'Deodorant compositions' [patent_app_type] => utility [patent_app_number] => 13/344237 [patent_app_country] => US [patent_app_date] => 2012-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10513 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13344237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607213 [patent_doc_number] => 20130012525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'INHIBITORS OF BRUTON\'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS' [patent_app_type] => utility [patent_app_number] => 13/341708 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 62874 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10553908 [patent_doc_number] => 09278100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'Inhibitors of bruton\'s tyrosine kinase for the treatment of solid tumors' [patent_app_type] => utility [patent_app_number] => 13/341695 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 63006 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8158447 [patent_doc_number] => 20120100138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-26 [patent_title] => 'THE USE OF INHIBITORS OF BRUTON\'S TYROSINE KINASE (BTK)' [patent_app_type] => utility [patent_app_number] => 13/340533 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 67068 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20120100138.pdf [firstpage_image] =>[orig_patent_app_number] => 13340533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363248 [patent_doc_number] => 08252312 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-08-28 [patent_title] => 'Oral solid composition comprising a lipid absorption inhibitor' [patent_app_type] => utility [patent_app_number] => 13/337432 [patent_app_country] => US [patent_app_date] => 2011-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3020 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13337432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140733 [patent_doc_number] => 20120094918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'METHOD OF USING DIKETOPIPERAZINES AND COMPOSITION CONTAINING THEM' [patent_app_type] => utility [patent_app_number] => 13/338056 [patent_app_country] => US [patent_app_date] => 2011-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6905 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094918.pdf [firstpage_image] =>[orig_patent_app_number] => 13338056 [rel_patent_id] =>[rel_patent_doc_number] =>)